Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasonographic Assessment of Masseter Muscle After Botulinum Toxin in Bruxism
NCT07545200Completed
- Sponsor
- Kahramanmaraş Sütçü İmam Üniversitesi
- Start
- Sep 2025
- Primary completion
- Feb 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of botulinum toxin type A in bruxism, sponsored by Kahramanmaraş Sütçü İmam Üniversitesi. Primary endpoint: Masseter Muscle Thickness at Day 90. Started Sep 2025; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
bruxism
Beyond the preview
Go deeper on NCT07545200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07545200.